Here are the DEF 14A proxy statements from PROCEPT BioRobotics Corporation (PRCT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PRCT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRCT filings page.
PROCEPT BioRobotics is calling a fully virtual 2026 annual stockholder meeting on June 9, 2026 at 1:00 p.m. Eastern Time. Stockholders will vote on electing three Class II directors (Antal Desai, Mary Garrett and Frederic Moll, M.D.), ratifying PricewaterhouseCoopers LLP as auditor for 2026, and approving, on an advisory basis, executive compensation.
The record date is April 10, 2026, and all voting can be done online, by phone, mail or during the webcast. The proxy also reviews 2025 performance, including revenue of $308.1 million (up from $224.5 million in 2024), approximately 43,300 U.S. procedures, 718 installed systems and a 64% gross margin, as well as a leadership transition to CEO Larry L. Wood.